Tyra Biosciences, Inc.
TYRA
$10.04
-$0.05-0.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -12.01% | -13.54% | -40.91% | -53.13% | -77.05% |
| Total Depreciation and Amortization | 41.18% | 53.01% | 41.57% | 46.99% | 24.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 87.78% | 36.35% | 0.59% | 18.62% | 1.03% |
| Change in Net Operating Assets | -94.92% | 105.08% | 455.73% | -1,316.98% | 401.40% |
| Cash from Operations | -44.77% | -4.39% | -6.69% | -123.70% | -12.95% |
| Capital Expenditure | 99.00% | 37.35% | -993.02% | -231.71% | -2,771.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 104.84% | -- | -- | -- | -- |
| Cash from Investing | 104.82% | 26,072.29% | -337,088.37% | 44,180.49% | -687,700.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 117.90% | 59.10% | 68.65% | 53,220.21% | 10,700.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 117.90% | 59.10% | 0.81% | 53,175.27% | 10,700.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 92.43% | 126.26% | -1,567.48% | 2,164.34% | -1,213.94% |